University Of California San Francisco
Large study of black men with prostate cancer to look beyond genetics
Alcohol relapse score predicts early liver transplant eligibility
Three researchers to be honored at San Antonio Breast Cancer Symposium
Infliximab biosimilar 'only moderately' less costly vs. biologic under Medicare Part D
Prostate Cancer Foundation presents Young Investigator Awards
The liberating message of ‘Undetectable = Untransmittable’

As ID professionals, we all are familiar with the concept of HIV treatment as prevention, or TasP. The science establishing TasP as an effective medical and public health strategy was established by HPTN 052, a randomized clinical trial involving 1,763 serodiscordant couples from nine different countries, which showed a 93% reduction in transmission risk in couples in which the infected partner was assigned to early ART. The implications of this finding were so significant that in 2011, Science highlighted the study as its “Breakthrough of the Year.” Collectively, results from HPTN 052 and several other landmark studies have validated that people living with HIV who have maximally suppressed virus on ART do not sexually transmit HIV to their partners. But surprisingly, this information has not been conveyed to the affected community in a meaningful way that would allow them to share its benefits.
American Society for Radiation Oncology members receive fellow designation
Excessive napping indicates elevated dementia risk in older men
Studies review effect of overlapping spine surgery on outcomes

Spine and orthopedic surgery that is concurrent or overlapping is a hot topic that has led hospitals and investigators to examine this practice at their institutions. Two retrospective reviews published in the Journal of Neurosurgery showed the effect on outcomes after neurosurgery performed when two procedures were overlapping, or surgical steps were performed concurrently in different cases at any time during surgery.
AGA working group to address myths about IBD, pregnancy

To better guide women with inflammatory bowel disease throughout all stages of family planning, the American Gastroenterological Association is partnering with pharmaceutical company UCB, the Crohn’s & Colitis Foundation and the Society for Maternal-Fetal Medicine to create a working group to address some of the myths surrounding pregnancy and inflammatory bowel disease.